Tumor Volume Reduction After Gemcitabine Plus Cisplatin Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: Comparison with Paclitaxel and Cisplatin Regimens

BACKGROUND: Gemcitabine plus cisplatin (GP) is a novel regimen of induction chemotherapy (IC) for treating locoregional advanced nasopharyngeal cancer (NPC). This retrospective study aimed to compare the efficacy of GP and TP (paclitaxel plus cisplatin) regimens in tumor volume reduction after IC. M...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Med Sci Monit
Autores principales: Zheng, Li, Liao, Wenjun, Xu, Peng, Li, Baisen, Wen, Hao, Zhang, Shichuan
Formato: Artigo
Lenguaje:Inglês
Publicado: International Scientific Literature, Inc. 2018
Materias:
Clinical Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237045/
https://ncbi.nlm.nih.gov/pubmed/30406770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.909736
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares